Join Isabel and Jade for this special episode of the GOLD podcast as three of last year's guests share their predictions for the pharmaceutical industry in 2024. The panel includes Matt Lewis from Inizio, Rick Hollis from Ipsen and Claudia Martinez from the Access to Medicine Foundation, all of whom share their predictions in their areas of expertise. But that's not all. The GOLD hosts also reminisce about the team's 2023 predictions podcast to see if these guests could really see the future ..read more

The Season 6 finale of the GOLD podcast has landed! Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals.  In this episode, Kinnari shares her thoughts on how the industry can engage the next generation of scientific leaders to propel itself into the future. Tune in to find out what might be stopping the younger generation from pursuing a career in pharma and how the industry can work to change their minds, the benefits of a more diverse workforce, the future of drug development and more. If you’re intereste ..read more

For each episode of Season 6, the GOLD team has asked its podcast guests to reflect on the same question: what gets you up in the morning, and what keeps you up at night?   As Season 6 nears its close, Isabel brings you a curated selection of insights from the leaders we have heard from so far. Tune in to find out what motivates these pharma aficionados and what they see as the key challenges in the industry today.   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:  GOLD's latest roundtable: Was it worth t ..read more

Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb. In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: Going for gold ..read more

Tune in to hear the latest insights from GOLD’s most recent catalyst interview with Peter Ahnesorg, Global Hematology Franchise Head, Roche.  In this exclusive teaser for the full interview, Jade dissects some of Peter’s thoughts on his entry into the pharmaceutical industry, Roche’s dedication to ensuring equitable access to its medicines and some of the qualities of a good leader that Peter has picked up along his career.  Additional resources   If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: &nb ..read more

Tune in to the latest episode of the GOLD podcast as Isabel and Jade present a discussion with Jaime Manzanera Gómez, EMEA Brand Director, Oncology, Eisai, who details how oncology teams can best increase the pace of innovation in the field. In this episode, Jaime shares his thoughts on the pace of innovation after the heights of COVID-19, how regulatory constraints can sometimes affect the industry's thirst for innovation, his passion for the outdoors and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: &nb ..read more

Listen in to the newest episode of the GOLD podcast, in which Jade digs deep into the diversity, equity and inclusion (DE&I) space with Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis. In the interview, the pair discuss why Marion left a career in commercial for DE&I, the need for more action on health inequities, Novartis's approach to creating a more diverse medical workforce and much more. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:   Roche's Davidek ..read more

Tune in to a new episode of the GOLD podcast as hosts Isabel and Jade discuss a timely topic for the pharmaceutical industry: how to build trust with healthcare professionals. With a recent survey showing that 80% of HCPs don't trust the content the industry produces for them, the team look at the story behind the statistic. They explore where the problems lie and how the industry can improve for the benefit of its customers. GOLD also hears from Rob Verheul, CEO, Graphite Digital, the company behind the report, who shares his takeaways from the research. These include the importance of data a ..read more

Discover the reality behind the expectations of rare disease research and drug development with Isabel and Jade as they present a discussion with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer.   Tune in to hear Ian and Isabel discuss the current pharmaceutical landscape for rare diseases, including discussions around clinical trials, partnering early in the drug lifecycle, what the industry should be keeping in mind for the future of the field and much more.    If you’re interested in learning more about the topic areas discussed in this episode, check ..read more

Tune in to the latest episode of the GOLD podcast as Nate Cope, Chief Operating Officer, Otsuka Europe, details how companies can drive innovation by being a great place to work. In this episode, Nate reveals the story behind his passion for prioritising people, what companies should and shouldn't do in their mission to become more people-centric and an example of how Otsuka sought to reward its employees for getting better sleep. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 4 top tips to create the perfect ERG The dri ..read more